FN2 Earnings Intelligence
Omega Healthcare Investors, Inc. financials
Omega Healthcare Investors, Inc. (OHI) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $20.5 | $297.1 | $442.8 | $518.3 | $27 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $1,062.8 | $878.2 | $949.7 | $1,051.4 | $1,190.1 |
| % Growth | 19.1% | -17.4% | 8.1% | 10.7% | 13.2% |
| Gross Profit | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| Net Income | $428.3 | $438.8 | $248.8 | $417.8 | $590.2 |
| % Margin | 40.3% | 50.0% | 26.2% | 39.7% | 49.6% |
| Diluted EPS | $1.75 | $1.80 | $1.00 | $1.55 | $1.94 |
| % Growth | 150.0% | 2.9% | -44.4% | 55.0% | 25.2% |
| Operating Cash Flow | $722.1 | $625.7 | $617.7 | $749.4 | $878.6 |
| CapEx | $44.9 | $47.2 | $38 | $37.8 | $80.9 |
| Free Cash Flow | $677.2 | $578.5 | $579.7 | $711.7 | $797.7 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue | $1,062.8 | $878.2 | $949.7 | $1,051.4 | $1,190.1 |
| Gross Profit | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Net Income | $428.3 | $438.8 | $248.8 | $417.8 | $590.2 |
| Diluted EPS | $1.75 | $1.80 | $1.00 | $1.55 | $1.94 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $20.5 | $297.1 | $442.8 | $518.3 | $27 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $5,253.5 | $5,286.8 | $5,067.3 | $4,838.9 | $4,256 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $722.1 | $625.7 | $617.7 | $749.4 | $878.6 |
| Capital Expenditure | $44.9 | $47.2 | $38 | $37.8 | $80.9 |
| Free Cash Flow | $677.2 | $578.5 | $579.7 | $711.7 | $797.7 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 19.1% | -17.4% | 8.1% | 10.7% | 13.2% |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 40.3% | 50.0% | 26.2% | 39.7% | 49.6% |
| FCF Margin | 63.7% | 65.9% | 61.0% | 67.7% | 67.0% |
| Diluted EPS Growth | 150.0% | 2.9% | -44.4% | 55.0% | 25.2% |
Get the OHI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.